Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025

Use of micro-ribonucleic acid (miRNA) to diagnose transplant rejection and tolerance of immunosuppression therapy

US Patent 11998331 · Granted Jun 4, 2024

Assignee

Inventors

View full patent text on Google Patents →